Reply commentary by Jalal and Burke
- PMID: 35410844
- DOI: 10.1016/j.drugpo.2022.103674
Reply commentary by Jalal and Burke
Conflict of interest statement
Declarations of Interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: DSB is co-founder and president of Epistemix, Inc., a start up company that creates and distributes software for computational modeling of complex health and social dynamics.
Comment in
-
What are the implications of the steady 40 year rise in US fatal overdoses?: Introduction to a special section.Int J Drug Policy. 2022 Jun;104:103693. doi: 10.1016/j.drugpo.2022.103693. Epub 2022 Apr 18. Int J Drug Policy. 2022. PMID: 35450794 No abstract available.
-
Fatal overdose: Predicting to prevent.Int J Drug Policy. 2022 Jun;104:103677. doi: 10.1016/j.drugpo.2022.103677. Epub 2022 May 9. Int J Drug Policy. 2022. PMID: 35550852 Free PMC article. No abstract available.
Grants and funding
LinkOut - more resources
Full Text Sources